|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 15 July 2003
doi: 10.1242/jcs.00673
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
5ß1 integrin
1 Molecular and Cell Biology Laboratory, IDI-IRCCS, via Monti di Creta 104,
00167 Rome, Italy
2 Pharmacology Laboratory, IDI-IRCCS, via Monti di Creta 104, 00167 Rome,
Italy
3 Laboratory of Molecular Biology, MRC Centre, Hills Road, Cambridge CB2 2QH,
UK, and CNR Center of Molecular Biology, c/o Department of Biochemical
Sciences, University of Rome 'La Sapienza', P.le A. Moro 5, 00185 Rome,
Italy
* Author for correspondence (e-mail: a.orecchia{at}idi.it)
Accepted 16 May 2003
Vascular endothelial growth factor receptor-1 (VEGFR-1) is a tyrosine
kinase receptor for several growth factors of the VEGF family. Endothelial
cells express a membrane-spanning form of VEGFR-1 and secrete a soluble
variant of the receptor comprising only the extracellular region. The role of
this variant has not yet been completely defined. In this study, we report
that the secreted VEGFR-1 is present within the extracellular matrix deposited
by endothelial cells in culture, suggesting a possible involvement in
endothelial cell adhesion and migration. In adhesion assays, VEGFR-1
extracellular region specifically promoted endothelial cell attachment.
VEGFR-1-mediated cell adhesion was divalent cation-dependent, and inhibited by
antibodies directed against the
5ß1 integrin. Moreover, VEGFR-1
promoted endothelial cell migration, and this effect was inhibited by
anti-
5ß1 antibodies. Direct binding of VEGFR-1 to the
5ß1 integrin was also detected. Finally, binding to VEGFR-1
initiated endothelial cell spreading. Altogether these results indicate that
the soluble VEGFR-1 secreted by endothelial cells becomes a matrix-associated
protein that is able to interact with the
5ß1 integrin, suggesting
a new role of VEGFR-1 in angiogenesis, in addition to growth factor
binding.
Key words: Angiogenesis, Soluble receptor, Integrin, VEGFR-1
Related articles in JCS:
This article has been cited by other articles:
![]() |
R. Silva, G. D'Amico, K. M. Hodivala-Dilke, and L. E. Reynolds Integrins: The Keys to Unlocking Angiogenesis Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1703 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Kappas, G. Zeng, J. C. Chappell, J. B. Kearney, S. Hazarika, K. G. Kallianos, C. Patterson, B. H. Annex, and V. L. Bautch The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching J. Cell Biol., May 28, 2008; 181(5): 847 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Soro, A. Orecchia, L. Morbidelli, P. M. Lacal, V. Morea, K. Ballmer-Hofer, F. Ruffini, M. Ziche, S. D'Atri, G. Zambruno, et al. A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through {alpha}5{beta}1 integrin Blood, April 1, 2008; 111(7): 3479 - 3488. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tian, C.-h. Zhu, X.-w. Zhang, X. Xie, X.-l. Xin, Y.-h. Yi, L.-p. Lin, M.-y. Geng, and J. Ding Philinopside E, a New Sulfated Saponin from Sea Cucumber, Blocks the Interaction between Kinase Insert Domain-Containing Receptor (KDR) and {alpha}vbeta3 Integrin via Binding to the Extracellular Domain of KDR Mol. Pharmacol., September 1, 2007; 72(3): 545 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pillozzi, M. F. Brizzi, P. A. Bernabei, B. Bartolozzi, R. Caporale, V. Basile, V. Boddi, L. Pegoraro, A. Becchetti, and A. Arcangeli VEGFR-1 (FLT-1), {beta}1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome Blood, August 15, 2007; 110(4): 1238 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D'Arcangelo, V. Ambrosino, M. Giannuzzo, C. Gaetano, and M. C. Capogrossi Axl receptor activation mediates laminar shear stress anti-apoptotic effects in human endothelial cells Cardiovasc Res, September 1, 2006; 71(4): 754 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marcellini, N. De Luca, T. Riccioni, A. Ciucci, A. Orecchia, P. M. Lacal, F. Ruffini, M. Pesce, F. Cianfarani, G. Zambruno, et al. Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor Am. J. Pathol., August 1, 2006; 169(2): 643 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Das, H. Yeger, R. Tsuchida, R. Torkin, M. F.W. Gee, P. S. Thorner, M. Shibuya, D. Malkin, and S. Baruchel A Hypoxia-Driven Vascular Endothelial Growth Factor/Flt1 Autocrine Loop Interacts with Hypoxia-Inducible Factor-1{alpha} through Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase 1/2 Pathway in Neuroblastoma Cancer Res., August 15, 2005; 65(16): 7267 - 7275. [Abstract] [Full Text] [PDF] |
||||